Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

SELL
$218.29 - $256.91 $76,619 - $90,175
-351 Reduced 20.2%
1,387 $352,000
Q1 2022

May 09, 2022

SELL
$243.64 - $270.48 $57,499 - $63,833
-236 Reduced 11.96%
1,738 $462,000
Q4 2021

Feb 09, 2022

SELL
$230.08 - $250.94 $65,572 - $71,517
-285 Reduced 12.62%
1,974 $496,000
Q3 2021

Nov 10, 2021

SELL
$232.72 - $256.47 $370,955 - $408,813
-1,594 Reduced 41.37%
2,259 $555,000
Q2 2021

Aug 04, 2021

BUY
$232.65 - $254.58 $60,721 - $66,445
261 Added 7.27%
3,853 $937,000
Q1 2021

May 11, 2021

BUY
$232.09 - $256.88 $78,446 - $86,825
338 Added 10.39%
3,592 $873,000
Q4 2020

Feb 02, 2021

BUY
$221.92 - $245.94 $93,650 - $103,786
422 Added 14.9%
3,254 $814,000
Q3 2020

Nov 06, 2020

SELL
$215.77 - $276.76 $4.45 Million - $5.71 Million
-20,632 Reduced 87.93%
2,832 $659,000
Q2 2020

Aug 12, 2020

BUY
$219.9 - $263.41 $491,036 - $588,194
2,233 Added 10.52%
23,464 $5.61 Million
Q1 2020

May 06, 2020

BUY
$195.69 - $279.01 $591,962 - $844,005
3,025 Added 16.62%
21,231 $4.88 Million
Q4 2019

Feb 06, 2020

BUY
$236.45 - $266.82 $4.3 Million - $4.86 Million
18,206 New
18,206 $4.95 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Oxbow Advisors, LLC Portfolio

Follow Oxbow Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxbow Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxbow Advisors, LLC with notifications on news.